78 H 123 N 23 O 23 S 2 AOD-9604 Mechanism of Action Models the C-terminal lipolytic domain of human growth hormone (residues 176191) with an added N-terminal tyrosine
The World Anti-Doping Agency (WADA) includes it under the category of S0 Non-approved Substances, which covers any pharmacological agent that has not been approved for human use by a regulatory authority
SeekPeptides members get access to the latest research updates, detailed protocol guides, and a community of experienced researchers who share real-world outcomes from their protocols
Common Mistakes to Avoid to Store Bacteriostatic Water Safely Leaving vials unsealed even a short time uncovered can lead to contamination
We've seen it happen, and it's a catastrophic, entirely preventable outcome
Interestingly, HGF also reduces a caspase-independent ischemic neuronal cell death by preventing apoptosis-inducing factor (AIF) translocation downstream of poly(ADP-ribose)polymerase 1 (PARP1) and p53 (Cregan et al., 2004
